National Health Investors (NHI) Reports In-Line Q2 FFO

National Health Investors (NYSE: NHI) reported Q2 EPS of $1.38, in-line with the analyst estimate of $1.38.

GUIDANCE:

National Health Investors sees FY2018 EPS of $5.47-$5.51, versus the consensus of $5.50.

For earnings history and earnings-related data on National Health Investors (NHI) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Klarna Group plc (KLAR) Tops Q2 EPS by 6c, Beats on Revenue; Offers FY26 Revenue Guidance
• Amer Sports, Inc. (AS) Tops Q2 EPS by 11c; raises guidance